DANIEL L. MARKS, MD
Medical Practice at Sam Jackson Park Rd, Portland, OR
License number
Oregon MD21193
Category
Medical Practice
Type
Pediatric Endocrinology
Address
Address
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Phone
(503) 418-5710
(503) 494-1927
(503) 494-1933 (Fax)
(503) 494-1927
(503) 494-1933 (Fax)
Personal information
See more information about DANIEL L. MARKS at radaris.comName
Address
Phone
85106 Joseph Hwy, Enterprise, OR 97828
1225 Yamhill St, Portland, OR 97214
7234 SE 18Th Ave, Portland, OR 97202
7234 18Th Ave, Portland, OR 97202
Organization information
See more information about DANIEL L. MARKS at bizstanding.comDaniel L Marks MD
700 SW Campus Dr #7, Portland, OR 97239
Categories:
Physicians & Surgeons
Phone:
(503) 418-5710 (Phone)
Professional information
Pediatric Endocrinologist
Position:
Pediatric Endocrinologist at St Luke's Children's Hospital, Scientist at OHSU, Pediatric Endocrinologist at Doernbecher Children's Hospital
Location:
Portland, Oregon Area
Industry:
Research
Work:
St Luke's Children's Hospital
since Jan 2009
-
Pediatric Endocrinologist
OHSU
- Portland, OR since 1998
-
Scientist
Doernbecher Children's Hospital
- Portland, Oregon since 1998
-
Pediatric Endocrinologist
Education:
University of Washington School of Medicine
Skills:
Molecular Biology, In Vivo, Animal Models, In Situ Hybridization, Neuroscience, Cancer
Dr. Daniel L Marks, Portland OR - MD (Doctor of Medicine)
Specialties:
Pediatric Endocrinology
Address:
Harold Schnitzer Diabetes Health
3181 SW Sam Jackson Park Rd SUITE 140, Portland 97239
(503) 494-3273 (Phone)
St. Luke's Children's Endocrinology
100 E Idaho St, Boise 83712
3181 SW Sam Jackson Park Rd SUITE 140, Portland 97239
(503) 494-3273 (Phone)
St. Luke's Children's Endocrinology
100 E Idaho St, Boise 83712
Certifications:
Pediatric Endocrinology, 2001, Pediatrics, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Harold Schnitzer Diabetes Health
3181 SW Sam Jackson Park Rd SUITE 140, Portland 97239
St. Luke's Children's Endocrinology
100 E Idaho St, Boise 83712
OHSU Hospital
3181 West Sam Jackson Park Rd, Portland 97239
St. Luke's Regional Medical Center
190 East Bannock St, Boise 83712
3181 SW Sam Jackson Park Rd SUITE 140, Portland 97239
St. Luke's Children's Endocrinology
100 E Idaho St, Boise 83712
OHSU Hospital
3181 West Sam Jackson Park Rd, Portland 97239
St. Luke's Regional Medical Center
190 East Bannock St, Boise 83712
Philosophy:
As health care providers affiliated with St. Luke's Children's Hospital, we believe that all children should have access to the highest quality health care services available, regardless of their condition or their family's ability to pay. The Children's Hospital is home to a wide variety of experienced pediatric subspecialists who are committed to the health and wellness of all children.
Education:
Medical School
University Of Washington School Of Medicine
Graduated: 1995
Or Health Science University Hospital
University Of Ut Med Center
University Of Washington School Of Medicine
Graduated: 1995
Or Health Science University Hospital
University Of Ut Med Center
Electromechanical Engineer At Reference Pcb
Position:
Electromechanical Engineer at Reference PCB
Location:
Portland, Oregon Area
Industry:
Electrical/Electronic Manufacturing
Work:
Reference PCB
-
Electromechanical Engineer
Daniel Lee Marks, Portland OR
Specialties:
Pediatrics, Pediatric Endocrinology
Work:
Harold Schnitzer Diabetes Health Center
3181 SW Sam Jackson Park Rd, Portland, OR 97239
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Education:
University of Washington (1995)
Daniel Lee Marks, Portland OR
Specialties:
Pediatric Endocrinologist
Address:
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
707 Sw Gaines St, Portland, OR 97239
707 Sw Gaines St, Portland, OR 97239
Methods And Reagents For Using Mammalian Melanocortin Receptor Antagonists To Treat Cachexia
US Patent:
2003011, Jun 19, 2003
Filed:
Feb 13, 2002
Appl. No.:
10/074754
Inventors:
Daniel Marks - Portland OR, US
Roger Cone - Oregon City OR, US
Roger Cone - Oregon City OR, US
Assignee:
Oregon Health and Sciences University, a non-profit organization - Portland OR
International Classification:
A61K049/00, A61K031/00, G01N033/567
US Classification:
424/009200, 435/007210, 514/001000
Abstract:
The present invention provides recombinant expression constructs comprising nucleic acid encoding mammalian melanocortin receptors, in particular MC-4 melanocortin receptor, and mammalian cells into which said recombinant expression constructs have been introduced that express functional mammalian MC-4 melanocortin receptors. The invention particularly provides such genetically engineered cells expressing the human MC4-R melanocortin receptor for screening compounds for receptor agonist and antagonist activity. The invention also provides screening methods using genetically engineered cells expressing the human MC-4 melanocortin receptor to specifically detect and identify agonists and antagonists for this melanocortin receptor. Such screening methods are provided identifying compounds with MC-4 melanocortin receptor antagonist activity having the capacity to influence or modify metabolism and feeding behavior, particularly pathological feeding behavior such as illness-induced cachexia.